Liu Y, Sarkar A, Kheradpour P, Ernst J, Kellis M. Evidence of reduced recombination rate in human regulatory domains. Genome Biol. 2017;18(1):193. doi:10.1186/s13059-017-1308-x
Matthews BJ, Dudchenko O, Kingan SB, et al. Improved reference genome of Aedes aegypti informs arbovirus vector control. Nature. 2018;563(7732):501-507. doi:10.1038/s41586-018-0692-z
Jarosz DF, Khurana V. Specification of Physiologic and Disease States by Distinct Proteins and Protein Conformations. Cell. 2017;171(5):1001-1014. doi:10.1016/j.cell.2017.10.047
Doench JG. Am I ready for CRISPR? A user’s guide to genetic screens. Nat Rev Genet. 2018;19(2):67-80. doi:10.1038/nrg.2017.97
Gao X, Tao Y, Lamas V, et al. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature. 2018;553(7687):217-221. doi:10.1038/nature25164
Koh AS, Miller EL, Buenrostro JD, et al. Rapid chromatin repression by Aire provides precise control of immune tolerance. Nat Immunol. 2018;19(2):162-172. doi:10.1038/s41590-017-0032-8
Lupberger J, Croonenborghs T, Suarez AAR, et al. Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development. Gastroenterology. 2019;157(2):537-551.e9. doi:10.1053/j.gastro.2019.04.003
Jeselsohn R, Bergholz JS, Pun M, et al. Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations. Cancer Cell. 2018;33(2):173-186.e5. doi:10.1016/j.ccell.2018.01.004
Wang G, Chow RD, Ye L, et al. Mapping a functional cancer genome atlas of tumor suppressors in mouse liver using AAV-CRISPR-mediated direct in vivo screening. Sci Adv. 2018;4(2):eaao5508. doi:10.1126/sciadv.aao5508
Hajdinjak M, Fu Q, Hübner A, et al. Reconstructing the genetic history of late Neanderthals. Nature. 2018;555(7698):652-656. doi:10.1038/nature26151